LLY 全部观点

已加载 20 条观点条目,其中 1 条方向发生变化

在已加载记录中筛选
Schwab Network发布 2026-11-16
《Adam Coons On Defense; "No Touch" on NVDA, Avoiding HD and LOW Pre-Earnings》
$LLY看涨
AI 摘要 · Eli Lilly 具有一定防御性;随着减肥药持续上市,接下来是 Retatrutide/GLP-3,它可能成为一款颠覆格局、消灭竞争的产品。说话者称 LLY 与 Google 一样有 10% 至 20% 的上涨空间,两者可因不同原因、在不同情境下跑赢。

像 Google 这样你喜欢的股票。它财报后确实出现了下跌,但整体处于某种上行趋势。还有 Eli Lily。你认为这两只股票都有 10% 到 20% 的上涨潜力吗?

Share like Google that you liked. I mean, it saw that decline after the earnings, but it was in a somewhat upward trend. And Eli Lily. Do you think both of these stocks have a 10 to 20% upside potential?

至于 Eli Lilly,它同样算是一只偏防御性的股票,但他们推出的产品,以及我们看到各种减肥药不断推出。我相信“Retatrotide”是下一个即将投产的产品。有人称它为“GLP-3”。

这款药很可能成为他们在这个领域的颠覆性产品,并可能淘汰其余竞争对手。

As for Eli Lilly, it is once again a somewhat defensive stock , but the products they are putting forward and we see a continuation of the introduction of various obesity drugs.

I believe "Retatrotide" is next in the production line. Some people call it "GLP-3". This drug is likely to be a game-changer for them in this field, and may eliminate the rest of the competition.

Schwab Network发布 2026-11-13
《PPI Mostly Cool, AI at "Crossroads" Amid NVDA CEO Search》
$LLY看涨
AI 摘要 · Eli Lilly 是一个高溢价成长故事:在表现出色的一年里上涨35%,也是医疗保健板块上涨行情的领跑者之一;它凭借三款领先的 GLP1 产品抓住了医疗保健领域最大的机会,有利的人口结构持续为强劲的研发管线提供顺风,因此其高溢价估值是合理的。

Eli Lilly 是你名单上的名字之一。我猜这是对 GLP1 领域的押注,但请给我们讲讲你的投资逻辑。正是如此。Eli Lilly 今年表现很好,上涨了35%,确实是这轮医疗保健行情中的领跑者之一。

正如你提到的,他们凭借三款领先的 GLP1 产品,抓住了当前医疗保健领域最大的机会。

Eli Lilly is one of those names on your list. I'm betting this is a bet on the GLP1 space, but walk us through your thesis here. Exactly. You know, Eli Lilly's had a great year up 35% and really one of the leaders of that healthcare run.

As you mentioned, they've been able to capitalize on, you know, really the the biggest opportunity right now in healthcare with their three leading GLP1 products.

Schwab Network发布 2026-11-12
《The Big 3: JNJ, LLY, AAPL》
$LLY看涨
AI 摘要 · Eli Lilly 技术面强劲,说话者预计将出现一段有节制的上行:较快的移动平均线有利于多头,但该股尚未令人信服地突破 14.50 的上限,且 RSI 显示看跌背离。他更倾向于用期权结构在捕捉上行空间的同时限制下行风险,目标 1560–1600,理想涨幅 8–10%;该股估值偏高、期权操作难度大,而医疗保健板块到 2027 年应保持相对强势。

你的下一个选择也在医疗保健板块。我们有 Eli Lilly。我是说,也许 Eli Lilly 的图表在技术面上更清晰。那么,你对 Lilly 的前景怎么看?观点类似。从技术角度看,动量肯定是在的。

但同样,我从根本上认为,随着我们进入2027年,医疗保健板块将继续展现出相对强度。这是一只昂贵的股票。由于股票的规模和期权的成本,很难在它上面构建期权头寸。不过,我仍然相信有机会,这就是为什么我今天看交易示例时,重点是在期权上构建一笔交易。

因此,在某种程度上,我们识别下行风险,同时具备捕捉价格上涨的能力。

Your next choice is also in the healthcare sector. We have Eli Lilly. I mean, perhaps Eli Lilly's chart is more technically clear. So , what is your outlook for Lilly? A similar view.

The momentum is definitely there from a technical standpoint. But again, I fundamentally believe that the healthcare sector will continue to demonstrate relative strength as we enter 2027.

It is an expensive stock. It is difficult to structure options positions on it due to the size of the stock and the cost of the options as well. However, I still believe there are opportunities, and that's why when I looked at the trading example today, the focus was on structuring a deal around options.

Therefore, to some extent, we identify downside risks with the ability to capture upward price movements.

Parkev Tatevosian, CFA发布 2026-11-10
《My Forever Portfolio: 4 Spectacular Stocks You Can Buy Now and Never Sell》
$LLY看涨
AI 摘要 · 礼来是一只可以永久买入并持有的推荐标的,因为其数十年来接连不断的成功——不只是减肥药——使当前的成功并非昙花一现;股价为1,366美元,而他给出的估值为1,662美元,他持有该股并希望继续加仓。

你在这里看到的是我的估值,以及我为我要提到的第一只股票所做的现金流折现模型。这只股票你现在就可以买入并永久持有,它就是Eli Lilly。

What you see here is my valuation, and my discounted cash flow model for the first stock I'm going to mention that you can buy now and hold forever, which is Eli Lilly.

Eli Lilly是一家制药公司,在研发治疗药物方面拥有数十年经验,这些药物带来了数十亿美元的销售额和利润。目前,该公司正受益于其在减肥治疗领域最近取得的成功,但这家公司有着一个成功接着一个成功的历史。

Eli Lilly is a pharmaceutical company with decades of experience in researching and developing treatments that generate billions of dollars in sales and profits. Currently, the company is benefiting from its recent success in weight loss treatments, but the company has a history of one success after another.

Everything Money发布 2026-11-07
《Why The Nasdaq is Really Crashing in 2026 (Sell Now or Buy the Dip?)》
$LLY看跌
AI 摘要 · 暂无中文摘要,仅英文原句可核对。

礼来(Eli Lilly)这家以热门减肥疗法闻名的制药公司,股价创下近1450美元/股的历史新高。其销售额在上个季度大幅跃升了39%。

Eli Lilly, the pharmaceutical company responsible for popular weight-loss treatments, hit a record high of nearly $1,450 per share. Its sales jumped by a massive 39% in the last quarter.

《Stock Market Warning: Tech Sells Off as Money Moves HERE!》
$LLY看涨
AI 摘要 · Eli Lilly 估值昂贵,但今日刚进入买入区间,且在全新的加号底部形态上提供了又一次买入机会;由于医疗交易相当活跃,Lilly 现在看起来相当有前景。

这是一只昂贵的股票。它的名字是 Eli Lilly,它今天刚刚进入买入区间,又给了你一次机会。我相信它们总是会再给你一次机会。而且它处在一个漂亮的新鲜基底上。它上涨了,而因为市场不好,它又给了你一次机会。

所以像 Lilly 这样的股票现在看起来相当有前景,因为医疗板块的交易现在相当活跃。

This is an expensive stock. Its name is Eli Lilly and it just arrived at the Buy Zone today and gave you another chance. I believe they always give you another chance. And it's on a nice fresh plus base.

It went up and because the market was bad, it gave you another chance. So stocks like Lilly look quite promising now because the medical trade is quite active now.

T3 Live发布 2026-11-03
《Scott Redler’s #630club - LIVE Premarket Stock Market Update》
$LLY看涨
AI 摘要 · LLY 表现非常出色,技术面走势良好——它向上突破并守住了 8 日均线;说话者表示要看 1387 的低点能否守住。

太多东西都坏掉了。是的,非科技股看起来还行。所以,如果你想持有 Eli Liy,Eli Liy 的表现一直非常出色。如果你想靠吃药减肥,我不评判你,你也可以那么做。我打算去我儿子那儿,泡我的冰桶,出一身汗。

但全世界有7%的人在吃药减肥。好吧。总之,这只股票的技术面一直表现不错。给了你一波行情,守住了8日线。我有个朋友,他每个孩子的大学学费都是他付的,因为他给小女儿取名叫 Lily。

Lily 走出了一波巨大的行情。它跌了11,1397。这里的低点是多少?1387。所以,看看这个位置能不能守住。

So many freaking broken stuff. Yes, non tech looks okay. So, if you want to be in Eli Liy, Eli Liy has been doing absolutely fantastic. You know, if you want to take a pill to lose weight, I'm not judging you.

You could do that, too. I'm going to go on my son and my ice barrel and I'm going to sweat. But 7% of the world is taking pills to lose weight. Okay. Anyway, um stock technically has been acting well.

Gave you a move, held the eight day. Um go, you know, I have a friend who who's paying for every one of his kids college because he named his little daughter Lily. And uh Lily has had a tremendous run.

It's down 11 1397. Um what's this low here? 1387. So, um, see if that holds.

他说在等
1387低点是否守住
守住1387
近期1387低点处的价格走势
支持建设性的技术面观点
Verified Investing发布 2026-11-02
《Oil Drops Sharply Triggering Market Surge, Silver Bounces As AI Tech Trade Is Back On, Top Trades!》
$LLY看跌
AI 摘要 · Eli Lilly 是说话者目前最看好的做空标的之一。在 AI 交易崩盘之际它刚创新高,周五的小十字星可能是反转信号,下跌或许已经开始。他关注价格跌至 1290 附近以回补枢轴位缺口,这是经典的回调形态。

各位,目前我最喜欢的做空标的之一就是这只——Eli Lilly。还是Eli Lilly,如果你看月线图,你和我都会发誓这是一只AI股票,但它实际上是一只制药股。近期人工智能领域出现了重大行情。

看看这里的上涨走势:当AI交易在崩盘时,Eli Lilly却涨到了新的历史高点。周五录得一根小“十字星”K线,这可能是反转信号。再说一次,有可能开始下跌。我会关注它是否跌到1290附近。

回补这个缺口也正好对应这个枢轴点的高点,对吧?所以再说一次,先回补那里的缺口,然后是那个枢轴点。Eli Lilly的股票形态看起来很可能出现一次经典的回落机会。

One of my favorite short-selling deals right now, guys, is this one. Eli Lilly. Eli Lilly again, if you go to your monthly chart, you would swear and I would swear that this is an AI stock, but it is actually a pharmaceutical stock.

A major movement recently in artificial intelligence. Look at this upward movement here: while the AI trade was collapsing, Eli Lilly rose to new record highs. A small "Doji" candlestick was recorded on Friday, which could be a reversal signal.

Once again, there is a possibility of a decline beginning. I'll be watching for a drop to around 1290 here. Bridging this gap also represents the peak of this pivot point here, isn't it?

So again, bridge the gap there and then that pivot point there. A classic pullback opportunity seems likely in Eli Lilly's stock setup .

Meet Kevin发布 2026-10-31
《You've been WARNED.》
$LLY看涨
Rich Habits发布 2026-10-30
《Anthropic $2 Trillion IPO, Apple's "Crackgate," & Retatrutide Results》
$LLY看涨
Ale's World of Stocks发布 2026-10-29
《The REAL Reason BlackRock Bet $80B on Eli Lilly Stock 🚨》
$LLY看涨
AI 摘要 · 礼来是一流的长期股息成长股:股息实现两位数增长,派息率仅20%;Zepbound与Mounjaro上季度分别增长46%和91%,占据该市场60%以上份额;PEG低于行业平均水平。分析师预计营收和利润将继续增长,不过不足1%的股息率只有长期持有者才能获益。

今天,我们需要聊一聊市场上那些势不可挡的医疗保健巨头之一——礼来,其股票代码是“LLY”。从表面上看,大多数小投资者往往只关注这只股票创纪录的价格表现,而不太在意其不到1%的微薄股息率。

Today, we need to talk about one of the unstoppable healthcare giants in the market, Eli Lilly, whose ticker symbol is "LLY". On the surface, most small investors tend to focus on the stock's record price performance, without paying much attention to the meager dividend yield of less than 1%.

他说在等
未来季度财报中的营收和利润增长
持续增长
未来几个季度季度财报
支持长期增长逻辑
Schwab Network发布 2026-10-29
《Thursday's First Moves: FTNT Falls After Earnings, CAT Tumbles, LLY Rises》
$LLY看涨
AI 摘要 · LLY 本季度表现非常强劲并超出预期,调整后每股收益 7.48 美元(预期 6.50 美元),营收 244 亿美元(预期 226 亿美元),并上调了指引。其两款主要 GLP-1 药物均超出预期,合计约占季度营收的三分之二,显示出依赖性;减肥药尚未上市,这是一个较小的弱点,被上述药物所抵消。

最后但同样重要的是,Eli Lilly 有一些非常好的消息,GLP-1 药物也仍然是这个故事的一部分。是的,Eli Lilly 正在赢得减肥药之战,这些股票在季度业绩的推动下再次起飞,涨幅超过 7%。

业绩非常强劲,超出了预期;调整后每股收益为 7.48 美元,而市场预期为 6.50 美元;营收为 244 亿美元,而市场预期为 226 亿美元。所以这是一个超出预期并上调指引的季度。

last but not least, there is some really great news for Eli Lilly, and the GLP -1 drug is still part of the story as well. Yes, they are winning the weight-loss battles for Eli Lilly, and these stocks are taking off again with gains of more than 7 % on the back of their quarterly results.

Very strong results that exceeded expectations; Earnings of $7.48 per share on an adjusted basis versus the $6.50 expected by the market, and revenue of $24.4 billion versus the $22.6 billion expected by the market.

So it was a quarter that exceeded expectations with the guidance raised.

Schwab Network发布 2026-10-28
《Ghabour: Fed "Biggest Risk to Bull Market;" Bullish on MSFT, CRWD, LLY》
$LLY看涨
AI 摘要 · 礼来是一只值得看好的非科技股:其年化涨幅超过50%,年初至今也大幅跑赢,而礼来拥有市场份额的GLP-1品类是全球性现象,礼来在国际市场投入巨大。

科技板块之外有一个标的你可能会喜欢,那就是Eli Lilly。它的表现非常出色,按年计算大幅跑赢超过50%,甚至从年初至今也是如此。

There is one name outside the technology sector that you might like, and that is Eli Lilly. His performance has been outstanding, significantly outperforming on an annual basis by more than 50%, and even since the beginning of the year.

Meet Kevin发布 2026-10-20
《The NEXT Frontier: THESE 3 Stocks Boom》
$LLY看涨
AI 摘要 · 礼来是风险最低、最合理的选择:他称其为医疗健康领域的标普500式收购机器,凭借1.22万亿美元市值和资本不断收购成功的初创公司和竞争对手。其PEG约为1.9,低于他偏好的2,尽管业绩强劲,估值仍保持合理。

下一个期权的 PEG 大约为 1.9,这算是个有点魔力的数字,因为对这类公司中的一些,我倾向于 PEG 低于 2。就是这家公司,Eli Lilly。Eli Lilly 已经是一家市值万亿美元的公司,但我把它称为人工智能领域的“标普 500”。

因为周六的这次会议对 Moderna 来说可能结果非常糟糕,然后股价会跌回 140 美元,你就会把全部收益都亏掉。也可能进展非常顺利,股价能涨到 300 美元。这是你的高波动选项。

在我看来,你风险最低、最明智的选项,是像 Eli Lilly 这样的选项。

This next option has a PEG ratio of around 1.9, which is a bit of a magic number as I prefer to be under two for some of these providers. This is the company here. It's Eli Lilly.

Eli Lilly is already a trillion-dollar company , but I call it the "S&P 500" of artificial intelligence. Because this meeting on Saturday could go disastrously for Moderna, and then the stock will fall back to $140, and you will have lost all your gains.

It could also go very well, and the stock could reach $300. This is your high-volatility option. Your least risky and most sensible option, in my opinion, is an option like Eli Lilly.

Meet Kevin发布 2026-10-20
《The Pain Returns... ALREADY AI, Fed, Iran, SpaceX》
$LLY看涨
AI 摘要 · Eli Lilly是医疗保健领域AI敞口中风险最低的选择,风险低于那些高波动替代标的;尽管表现强劲,其估值仍然合理,PEG约1.9、低于2。它是医疗保健AI领域的标普500,凭借超过1万亿美元的市值和盈利能力收购竞争对手。

而这正是像 Eli Liy 这样的公司的一个好处。Eli Lily 现在的估值是多少?我们来看看。所以 Lily 现在,他们大概是24左右。我不觉得他们现在高得离谱。

And this is one of the benefits of like an Eli Liy. What's Eli Lily's valuation right now? Let's find out. So Lily right now, they're probably like a 24. I don't think they're like ridiculously high right now.

1300 / 328 = 39.6。6加,哦,这些预期可真够疯狂的。4,20.4。哦,那大概是2。39634除以20.4。对。哦,1.94。对 Eli Lily 来说这不算差。其实不算差。

1300 / 328 = 39.6. 6 plus Oh, those are some crazy estimates. 4 20.4. Oh, that's about a two. 39634 divided by 20.4. Yeah. Oh, 1.94. That's not bad for Eli Lily. It's actually not bad.

Verified Investing发布 2026-10-14
《AI Stocks Bleed As Money Rotates Into Walmart, Lockheed And Lilly》
$LLY看跌
AI 摘要 · LLY 今日上涨4%,正在拒绝自2026年4月30日低点引出的上升趋势线;1243-1244区域及1249.45枢轴高点可能有利于做空交易,而若向上突破,则在经历深度且健康的回调后可能测试1292.65双顶;支撑预计位于1133.95上方。

Walmart、Lockheed Martin,甚至 Eli Lilly,都是表现最强劲的。

Walmart, Lockheed Martin, and even Eli Lilly are the most prosperous.

最后,各位,Eli Lilly 今天在市场上正经历着最好的交易日之一,今天上涨了4%。我在图表上关注的是这条自2026年4月30日低点以来的上升趋势线。价格正是在这里受阻回落。

And finally, folks, Eli Lilly is having one of its best days in the market with a 4% gain today. What I'm watching here on the charts is this upward trend line from the low on April 30, 2026. This is exactly where the price is rejecting.

Ale's World of Stocks发布 2026-10-04
《5 Dividend GROWTH Stocks BlackRock is Buying Right Now! 🚨》
$LLY看涨
AI 摘要 · LLY是一只受青睐的股息增长股;高增长率与低派息率使其具吸引力,尽管股息率不足1%。

好,最后,这就把我们带到了名单上的第五笔也是最后一笔买入。为此,我们实际上要转向医疗保健板块,不过在这份名单上我们已经谈了很多科技。事实上,这家公司里也有很多科技。所以,变化不算很大,但我们来看这家公司,另一个大型股息增长标的,也就是制药巨头 Eli Lilly(交易代码 LLY),BlackRock 在上个季度又买入了 13 亿美元,使其总持股超过 800 亿美元。

Okay, finally, this now brings us to the fifth and final purchase on the list. For this, we're actually going to be heading towards the healthcare sector, but we've already talked a lot about technology on this list.

In fact, there is a lot of technology in this company as well. So, not a very big change , but let's move on to this company, another big dividend growth option , namely pharmaceutical giant Eli Lilly ( trading symbol LLY), of which BlackRock acquired another $1.3 billion in the last quarter, bringing their total stake to more than $80 billion.

Rich Habits发布 2026-10-02
《Leaked Anthropic Financials, Oura Ring Delays IPO, & America.gov》
$LLY看涨
AI 摘要 · LLY 的 Retatrotide 药物(减重 28%)为其 LLY 持仓带来 25-28% 的盈利,该药物正引发显著的正向关注。

你知道,使用 Eli Lilly、Novo Nordisk 或 Regeneron 的其中一种 GLP-1 药物,你会减掉 20% 的体重。

You know that you will lose 20% of your weight using one of these GLP-1 drugs, from Eli Lilly, Novo Nordisk , or Regeneron.

Eli Lilly 的 retatrotide 药物实现了 28% 的减重,患者报告日常活动能力有所改善。

Eli Lilly's retatrotide drug achieved a 28% weight loss, with patients reporting improvements in daily mobility.

Parkev Tatevosian, CFA发布 2026-09-28
《3 Undervalued Healthcare Stocks Invstors Can Buy Right Now》
$LLY看涨
AI 摘要 · LLY 目前被低估(公允价值 1,494 美元,现价 1,153 美元),受减肥药强劲势头与自由现金流增长推动,预计 12-18 个月内上涨约 30%。

我们将从一家市值约一万亿美元的公司,走向一家市值超过一万亿美元的公司,这家公司就是Eli Lilly。我无需解释Eli Lilly受益于什么;这一积极势头当然来自减肥治疗药物所创造的销售热潮,这让我想起Nvidia和Micron等人工智能公司的销售热潮。

We will move from a company with a market value of about one billion dollars to a company with a market value of more than one trillion dollars, which is Eli Lilly. I don't need to explain what Eli Lilly benefits from; the positive momentum is of course the weight loss treatments that have created a sales boom, which reminds me of the sales boom of artificial intelligence companies like Nvidia and Micron.

Ale's World of Stocks发布 2026-09-27
《Saudi Arabia is Secretly Loading Up on THESE 5 Stocks! 🚨》
$LLY看涨
AI 摘要 · LLY 在减重/糖尿病市场占据主导地位且研发管线强劲,是成长型投资的最佳选择,但股息率不高。

接下来看第二笔买入,我们其实还得留在制药板块,看另一家涨幅更大——如果你相信的话——的公司。这有点疯狂。这家公司就是最近市值达到万亿美元的制药巨头 Eli Lilly,交易代码是“LLY”,沙特本季度将其投资几乎翻倍,向这家公司投入了约 2800 万美元。

moving on to the second purchase, we actually have to stay within the pharmaceutical sector for another name that has achieved, if you believe it, an even greater rise. It's kind of crazy.

This name is the recently trillion-dollar pharmaceutical giant, Eli Lilly, whose trading symbol is “LLY”, in which Saudi Arabia has nearly doubled its investments this quarter, pumping about $28 million into this center.

继续看更早 →
其他股票的全部观点条目
把 $LLY 加入我的股票30 天完整试用
开始试用